Horgan, C., Elmoamly, S., McIlroy, G. et al. (9 more authors) (2019) Reduced intensity alemtuzumab-containing allogeneic stem cell transplantation for relapsed/refractory low grade lymphoma : reflections on a single center experience. Leukemia & Lymphoma, 60 (12). pp. 3075-3077. ISSN 1042-8194
Metadata
Item Type: | Article |
---|---|
Authors/Creators: |
|
Copyright, Publisher and Additional Information: | © 2019 Informa UK Limited, trading as Taylor & Francis Group. |
Keywords: | Alemtuzumab; Antineoplastic Agents, Immunological; Cause of Death; Drug Resistance, Neoplasm; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Prognosis; Recurrence; Retreatment; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome |
Dates: |
|
Institution: | The University of Sheffield |
Academic Units: | The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > The Medical School (Sheffield) > Academic Unit of Medical Education (Sheffield) |
Depositing User: | Symplectic Sheffield |
Date Deposited: | 24 Feb 2022 12:35 |
Last Modified: | 24 Feb 2022 12:35 |
Status: | Published |
Publisher: | Taylor & Francis |
Refereed: | Yes |
Identification Number: | 10.1080/10428194.2019.1607323 |
Related URLs: | |
Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:183864 |
Download not available
A full text copy of this item is not currently available from White Rose Research Online